Executive Summary
This digest covers 40 filings from September 23, 2026, dominated by M&A, insolvency, and delisting events, with a clear thematic split between distressed exits and strategic consolidation.
The most critical development is the wave of biotechnology and SPAC delistings, including Theravance Biopharma's Nasdaq exit following its acquisition by Zymeworks, and the forced delisting of Aditxt and ONE Nuclear Energy, signaling a shakeout in the sector. On the M&A front, Sun Communities' $1.03 billion sale of its UK business and Patrick Industries' merger with LCI Industries highlight a trend toward portfolio simplification and scale-building in industrial and housing end-markets. Insolvency proceedings continue for Winsome Yarns, Shirpur Gold Refinery, and Reliance Home Finance, with zero revenue and negative net worth underscoring terminal distress. A notable regulatory rejection occurred at Jindal Leasefin, where the RBI blocked an open offer, halting a change-in-control transaction. Period-over-period data is sparse across filings, but where available, it reveals a pattern of revenue erosion and margin compression in distressed entities, while cash-rich acquirers like Power Grid and Apogee Enterprises are deploying capital for strategic bolt-ons. The overall market implication is a bifurcation: well-capitalized firms are consolidating, while weak balance sheets are being flushed out, creating both risk and opportunity for event-driven investors.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from September 22, 2026.
Investment Signals (11)
- Sun Communities ↓ (BULLISH)▲
Completed $1.03B UK sale, becoming a pure-play North American MH/RV REIT; YTD share buybacks of $425M (3.5M shares) signal strong capital return focus
- Power Grid Corporation ↓ (BULLISH)▲
Acquired Barmer HVDC for ~₹19 Cr (BOOT basis), a 6,000 MW renewable evacuation project; zero revenue target with 24-month commercialization timeline, but strategic alignment with India's green grid buildout
- Apogee Enterprises ↓ (BULLISH)▲
Acquired GroGlass for up to $71.8M, adding anti-reflective coating tech; strengthens Performance Surfaces portfolio with premium brands serving museums and electronics
- Ugro Capital ↓ (BULLISH)▲
Shareholders voted 99.998% in favor of amalgamation with Profectus Capital; promoters voted 100% in favor, though only 39.55% turnout suggests retail apathy
- Jagsonpal Pharmaceuticals ↓ (BULLISH)▲
Acquired Wellness Portfolio via slump sale for ₹46.7Cr max; target had ₹24.6Cr turnover in FY26, implying ~1.9x sales multiple, accretive if earnout achieved
- StepStone Private Markets ↓ (BULLISH)▲
Tender offer fully subscribed, repurchased $146.4M across three share classes; 100% NAV pricing and strong participation signal investor confidence in fund's valuation
- Patrick Industries/LCI Merger ↓ (BULLISH)▲
Fixed exchange ratio of 1.2440 Patrick shares per LCI share; combined entity to own 52%/48% split; creates premier outdoor rec/housing component supplier with scale synergies
- Zymeworks ↓ (BULLISH)▲
Completed Theravance acquisition, adding YUPELRI and TRELEGY royalties; conference call Sept 28 to detail synergies; diversified revenue model reduces R&D risk
- Oscar Global ↓ (BEARISH)▲
Open offer at ₹10/share for only 3.60% of emerging capital due to ineligible preferential allottees (25.89%); massive dilution risk for public shareholders, offer cannot meet minimum 26% requirement
- SCWorx ↓ (BEARISH)▲
Nasdaq delisting hearing decision issued; stock suspended since April 2026; private placement of 350K shares may cure Publicly Held Shares deficiency, but bid price compliance deadline Oct 5, 2026
- Theravance Biopharma ↓ (NEUTRAL)▲
Delisted from Nasdaq effective Sept 23, 2026; CVR structure for ampreloxetine provides uncertain future cash flows tied to commercial milestones
Risk Flags (10)
- Winsome Yarns/Insolvency↓ [HIGH RISK]▼
Zero revenue from operations for Q2 FY27; net loss of ₹332 Lakhs; accumulated losses and negative net worth; transformer theft of ₹59.2 Lakhs; resolution plan implementation in progress
- Jindal Leasefin/Regulatory Rejection↓ [HIGH RISK]▼
RBI refused to approve change in management, forcing withdrawal of open offer by Tirupati Agrotech; deal collapse at 26% stake level; regulatory risk for future acquirers
- Aditxt/Delisting↓ [HIGH RISK]▼
Nasdaq to file Form 25 after hearings panel denied continued listing; stock suspended since June 25, 2026; now trades OTC; no path back to exchange
- ONE Nuclear Energy/Delisting [HIGH RISK]▼
Form 25-NSE filed for delisting of Rights and Units from Nasdaq effective Sept 23, 2026; former Hennessy Capital SPAC; failure to maintain listing standards
- Astrana Health/Cybersecurity↓ [MEDIUM RISK]▼
Social engineering attack on subsidiary; sensitive data accessed; investigation ongoing; though no material financial impact expected currently, litigation/reputational risk remains
- Shirpur Gold Refinery/Insolvency↓ [MEDIUM RISK]▼
31st CoC meeting held; company under CIRP; no resolution plan disclosed; prolonged process increases recovery uncertainty for creditors
- Reliance Home Finance/Insolvency↓ [MEDIUM RISK]▼
14th CoC meeting held; CIRP initiated Sept 2025; no financial outcomes disclosed; extended timeline suggests complex resolution
- International Media Acquisition Corp/SPAC Deadline↓ [MEDIUM RISK]▼
Deposited only $2,000 for 22nd of 24 monthly extensions; deadline extended to Nov 2, 2026; if no deal by then, SPAC likely liquidates
-
Transfer from Global to Capital Market effective Sept 24; typically signals failure to meet stricter listing requirements; no deficiency disclosed
- SEBI Enforcement/Jay Energy [LOW RISK]▼
Recovery proceedings against legal representative of deceased defaulter; indicates aggressive enforcement; may signal broader crackdown on defaulters
Opportunities (10)
- Sun Communities/Share Buybacks↓ (OPPORTUNITY)◆
$425M YTD repurchases (3.5M shares) funded by $1.03B UK sale proceeds; updated FY26 outlook on Q3 call; potential for accelerated buybacks if debt paydown completed
- Power Grid Corporation/Renewable Infrastructure↓ (OPPORTUNITY)◆
Barmer HVDC project (6,000 MW) on BOOT basis; 24-month commercialization; aligns with India's 500 GW renewable target by 2030; stable regulated returns
- Apogee Enterprises/GroGlass↓ (OPPORTUNITY)◆
$71.8M acquisition of anti-reflective coating leader; serves museums, electronics, architecture; bolt-on to Performance Surfaces; potential for cross-selling and margin expansion
- Zuari Industries/Portfolio Consolidation↓ (OPPORTUNITY)◆
Acquired 30.83% stake in Texmaco Infrastructure via block deal at ₹147.96 Cr; consolidates holdings at parent level; may precede further corporate restructuring
- Jagsonpal Pharmaceuticals/Wellness Portfolio↓ (OPPORTUNITY)◆
₹46.7Cr max consideration for ₹24.6Cr turnover portfolio; women's health focus; accretive if earnout achieved; expected close by Nov 1, 2026
- Ugro Capital/Amalgamation Vote↓ (OPPORTUNITY)◆
99.998% shareholder approval for Profectus Capital merger; promoters 100% in favor; consolidation creates larger NBFC with scale benefits; NCLT approval next catalyst
- Patrick Industries/LCI Merger↓ (OPPORTUNITY)◆
Fixed 1.2440 exchange ratio; combined entity to dominate outdoor rec/housing components; synergy realization over 12-18 months; special meetings to approve
- Zymeworks/Theravance Acquisition↓ (OPPORTUNITY)◆
Adds YUPELRI and TRELEGY royalties; conference call Sept 28; diversified revenue from commercial assets; potential for near-term cash flow inflection
- Cayson Acquisition Corp/SPAC Financing↓ (OPPORTUNITY)◆
$60K promissory note from CEO; non-interest bearing; forgivable if no deal; low-cost bridge financing; indicates active deal search
- Columbus Acquisition Corp/EGM↓ (OPPORTUNITY)◆
Reconvened EGM Sept 28 for WISeSat.Space merger; trust holds ~$10.79/share; redemption deadline Sept 24; potential for deal completion or liquidation arbitrage
Sector Themes (6)
- Biotech/Pharma Consolidation Accelerates◆
Two major deals (Zymeworks/Theravance, Apogee/GroGlass) and one delisting (Aditxt) in the same week; large-cap acquirers targeting commercial-stage assets with royalties; distressed biotechs face delisting risk if no deal found
- SPAC Liquidity Crisis◆
Multiple SPACs (International Media Acquisition, Range Capital, Cayson) extending deadlines with minimal trust deposits; Lakeshore transferring to Nasdaq Capital Market; ONE Nuclear Energy delisting; 2026 vintage SPACs face high failure rate
- Indian Insolvency Wave◆
Four filings (Winsome Yarns, Shirpur Gold, Reliance Home Finance, Ugro Capital) involve CIRP or NCLT proceedings; zero revenue and negative net worth common; resolution plans slow to implement; creditor recovery uncertain
- Regulatory Hurdles in M&A◆
Jindal Leasefin open offer withdrawn due to RBI non-approval; Oscar Global open offer structurally deficient (only 3.60% vs 26% minimum); SEBI enforcement against Jay Energy; regulatory risk rising for Indian change-of-control transactions
- Capital Return vs. Reinvestment◆
Sun Communities returning $425M via buybacks from asset sale; Power Grid and Apogee reinvesting in infrastructure/tech; bifurcation between cash-rich firms returning capital and growth-oriented acquirers deploying for scale
- Cybersecurity as Material Risk◆
Astrana Health's social engineering attack (phone spoofing) deemed material; sensitive data accessed; trend of operational risk disclosures increasing; insurance and remediation costs may impact earnings
Watch List (8)
-
Q3 2026 earnings call for updated FY26 outlook; watch for buyback pace and debt paydown details
-
Conference call Sept 28 at 8:30 am ET to discuss Theravance acquisition details; watch for synergy targets and revenue guidance
-
Reconvened EGM Sept 28 for WISeSat.Space merger; redemption deadline Sept 24; watch for shareholder vote outcome and potential liquidation
- 👁
Nasdaq bid price compliance deadline Oct 5, 2026; must show $1.00 closing bid for 10 consecutive days; stock currently OTC
-
Next extension deadline Nov 2, 2026; only 2 of 24 extensions remaining; watch for business combination announcement or liquidation
-
Wellness Portfolio acquisition expected to close by Nov 1, 2026; watch for integration updates and FY28 sales earnout
-
Barmer HVDC project 24-month commercialization timeline; watch for regulatory approvals and construction milestones
-
Special meetings for shareholder approvals; watch for regulatory clearance and exchange ratio adjustments
Filing Analyses
(40)
23-09-2026
Sun Communities completed the sale of its UK Park Holidays business to Aermont Capital for net cash proceeds of approximately $1.03 billion, positioning the company as a pure-play North American MH and RV platform. Year-to-date through September 21, 2026, the company repurchased approximately 3.5 million shares for about $425 million. Proceeds from the sale are expected to be used primarily for share repurchases, debt paydown, and general corporate purposes.
- · The sale was an all-cash transaction to Panther Bidco Limited, an affiliate of Aermont Capital.
- · Net cash consideration of approximately $1.03 billion is after customary locked-box adjustments and transaction costs.
- · The company expects to provide an updated full-year 2026 outlook on its Q3 2026 earnings call.
- · Lazard Frères & Co. LLC acted as lead financial advisor; BofA Securities, BMO Capital Markets, Citigroup, JP Morgan Securities LLC and Wells Fargo also acted as financial advisors.
- · Jones Day and Taft Stettinius & Hollister LLP acted as legal advisors to Sun; Rothschild & Co and Macfarlanes advised Aermont.
- · As of June 30, 2026, Sun owned/operated 455 developed properties with approximately 156,130 developed sites in the U.S. and Canada.
23-09-2026
23-09-2026
Astrana Health disclosed a material cybersecurity incident involving social engineering attacks on its subsidiary Astrana Health Management. Threat actors impersonated company personnel and spoofed the corporate phone number to gain unauthorized access to systems; the company believes private/confidential information was accessed. While the investigation is ongoing and the incident is deemed material due to sensitive data involved, the company currently does not expect a material effect on its financial condition or results of operations.
- · Incident detected by subsidiary Astrana Health Management, Inc.
- · Attack vector: social engineering with phone number spoofing
- · Remedial measures include credential resets, restriction of remote access tools, restoration from clean backups, and enhanced monitoring.
- · Company notified law enforcement, state and federal regulators, and payer partners.
- · Astrana maintains cybersecurity insurance, but coverage may not be sufficient for all losses.
- · Company intends to amend the 8-K as further information becomes available.
23-09-2026
Mr. Ghanshyam Hansrajani has launched an open offer to acquire up to 12,57,048 equity shares (26.00%) of Mayur Leather Products Ltd. at ₹27.92 per share, pursuant to a share purchase agreement with the existing promoters. Post-completion, the acquirer will gain control and become the new promoter, while the selling shareholders will be declassified from the promoter group. The offer is not conditional on minimum acceptance and is subject to compliance with minimum public shareholding requirements.
- · The open offer is not conditional upon any minimum level of acceptance by public shareholders.
- · The acquirer intends to retain the listing status of the target company on BSE; no delisting is proposed.
- · The acquirer does not currently intend to alienate, restructure, or dispose of any assets of the target company in the two years following the offer, except in the ordinary course.
- · Trading of the target company's equity shares on CSE is presently suspended; shares are actively traded only on BSE.
- · The target company is required to maintain a minimum public shareholding of 25% under SEBI LODR and SCRR rules.
- · The Detailed Public Statement was published on September 22, 2026, in four newspapers across English, Hindi, and Marathi editions.
23-09-2026
Saksoft Limited announced that the NCLT Chennai Bench has sanctioned the Scheme of Amalgamation of its wholly owned subsidiary, Augmento Labs Private Limited, with and into Saksoft Limited, effective from the Appointed Date of April 01, 2026. The order was received on September 22, 2026, and the scheme will become effective upon filing the certified copy with the Registrar of Companies, Chennai. The amalgamation is aimed at consolidating entities, simplifying the group structure, and achieving operational efficiencies, though the order contains typographical errors that will be rectified via a separate application.
- · NCLT order dated September 16, 2026, received by the company on September 22, 2026.
- · Appointed Date under the Scheme is April 01, 2026.
- · The Scheme will become effective upon filing the certified copy of the NCLT Order with the Registrar of Companies, Chennai.
- · The NCLT order contains typographical/clerical errors; the company will file a rectification application.
- · The amalgamation will result in cancellation of shares held by Saksoft in Augmento Labs without any payment or issue of new shares.
- · The amalgamation will be accounted for using the 'Pooling of Interest Method' as per Ind AS 103 (Appendix C).
23-09-2026
Samvardhana Motherson International Limited incorporated a new indirect subsidiary, MH Supply Chain Limited (MHSCL-US), in Delaware, USA on September 21, 2026, to provide logistics and supply chain solutions. The subsidiary is wholly owned by MHSCL JVC Holding Limited, UAE, in which Motherson holds 51% and Hellmann Worldwide Logistics (MESA) Holding Limited holds 49%. Initial subscribed capital is 1,000 shares at USD 0.01 per share, subscribed in cash.
- · Incorporation date of MHSCL-US: September 21, 2026
- · Delaware online government portal appearance date: September 22, 2026
- · Face value per share: USD 0.01
- · No governmental or regulatory approvals required for incorporation
- · Consideration is cash subscription, not share swap
23-09-2026
Saksoft Limited announced that the Hon'ble NCLT, Chennai Bench, has sanctioned the Scheme of Amalgamation of its wholly owned subsidiary Augmento Labs Private Limited (Transferor) with Saksoft Limited (Transferee), effective from the Appointed Date of April 01, 2026. The scheme, which involves no issue of new shares or cash payment, consolidates the group structure, simplifies compliance, and transfers all employees and employee benefit funds to the transferee on no less favorable terms. However, the NCLT order contains typographical/clerical errors, and the company will file a rectification application, with the scheme becoming effective only upon filing the certified copy with the Registrar of Companies.
- · NCLT order dated September 16, 2026, received by the company on September 22, 2026.
- · Appointed Date under the Scheme is April 01, 2026.
- · The scheme is accounted under the 'Pooling of Interest Method' as per Ind-AS 103 (Appendix C).
- · No new shares will be issued and no cash payment will be made by the Transferee Company for the amalgamation.
- · The NCLT order contains typographical/clerical errors; a rectification application will be filed.
- · Statutory authorities (Registrar of Companies, Income Tax Department) were noticed on February 04, 2026.
- · The Income Tax Department filed its report on June 05, 2026, with observations.
- · Employees of the Transferor Company will be absorbed on same terms and conditions, with past service counted for benefits.
23-09-2026
Shish Industries Limited's Board approved a Composite Scheme of Amalgamation to merge its two wholly-owned subsidiaries, Shish Polylam Private Limited and Shish Global Solutions Private Limited, into itself. The scheme aims to simplify the corporate structure, reduce compliance costs, and achieve operational synergies, with no new shares to be issued and no change in the company's shareholding pattern. The amalgamation is subject to regulatory approvals, including from the NCLT.
- · The scheme involves no cash consideration or share exchange ratio as the subsidiaries are wholly owned.
- · The shareholding pattern of Shish Industries Limited will remain unchanged post-scheme.
- · The Board meeting started at 3:00 PM and concluded at 4:00 PM on September 23, 2026.
- · The scheme is not classified as a related party transaction per Ministry of Corporate Affairs circular.
- · Shish Global Solutions Private Limited has a negative net worth of ₹(329.51) Lakh and negative total income of ₹(0.88) Lakh as of June 30, 2026.
23-09-2026
Ugro Capital Limited filed revised voting results for an NCLT-convened equity shareholders meeting held on September 22, 2026, regarding the Scheme of Amalgamation with Profectus Capital Private Limited. The resolution was passed as a special resolution with overwhelming support: 99.9983% of votes polled were in favor, with only 1,071 votes against (0.0017%). However, overall voter turnout was low at 39.55% of total outstanding shares, and no promoter or promoter group members attended the meeting in person or by proxy.
- · The meeting was convened pursuant to an order of the NCLT Mumbai Bench dated August 6, 2026.
- · The resolution required a special resolution (majority of not less than 75% of votes cast).
- · Promoter and promoter group held 4,477,061 shares and voted 100% in favor via e-voting.
- · Public institutions held 26,513,769 shares but only 3,151,090 (11.88%) voted, all in favor.
- · Public non-institutions held 124,297,493 shares; 53,783,331 (43.27%) voted, with 53,782,260 in favor and 1,071 against.
- · The revised filing corrected a typographical error in the previously submitted voting results.
23-09-2026
Ashoka Buildcon Limited has completed the acquisition of a 100% equity stake in Sakoli Power Transmission Limited, a project SPV, for a total consideration of Rs.3.06 Crore. The acquisition, which received Ministry of Power approval, was completed on September 23, 2026, and positions the company to develop a power transmission system on a BOOT basis. The SPV has nil turnover to date, with commercial operations scheduled within 24 months from the acquisition date.
- · The SPV was incorporated on July 07, 2025, and has no history of turnover for the last 3 years.
- · The scheduled date of commercial operation for the SPV is 24 months from the date of acquisition (September 23, 2026).
- · The acquisition does not fall within a related party transaction.
- · Approval has been received from the Ministry of Power for the share transfer.
23-09-2026
Shirpur Gold Refinery Ltd, currently under Corporate Insolvency Resolution Process (CIRP), held its 31st Committee of Creditors (CoC) meeting on September 23, 2026, via video conferencing. The meeting outcome was disclosed to stock exchanges as required under SEBI regulations. No specific financial figures, resolutions, or operational updates were provided in this filing.
- · The company is under Corporate Insolvency Resolution Process (CIRP).
- · Resolution Professional Ashish Vyas is IBBI registered (Regn. No.: IBBI/IPA-001/IP-P-01520/2018-2019/12267).
- · The meeting lasted 53 minutes (3:00 PM to 3:53 PM).
- · No resolution plan or specific outcome was disclosed in this filing.
23-09-2026
Pitti Engineering Limited (PEL) announced the effectiveness of its Scheme of Amalgamation with Pitti Industries Private Limited (PIPL) and Dakshin Foundry Private Limited (DFPL), effective September 23, 2026, with an appointed date of April 1, 2026. The scheme, sanctioned by the NCLT Hyderabad, involves the merger of the two private companies into PEL. As part of the scheme, PEL's authorized share capital has been amended to ₹196,89,25,000 (₹196.89 Cr) divided into 39,37,85,000 equity shares of ₹5 each.
- · The appointed date for the merger is April 1, 2026.
- · The scheme was sanctioned by the NCLT Hyderabad bench, with the order referenced in a prior letter dated September 8, 2026.
- · Form INC-28 was filed with the Registrar of Companies, Hyderabad on September 23, 2026, making the scheme effective.
- · The authorized share capital increased to ₹196,89,25,000 divided into 39,37,85,000 equity shares of ₹5 each.
23-09-2026
Jagsonpal Pharmaceuticals has entered into a Business Transfer Agreement to acquire the Wellness Portfolio of Group Pharmaceuticals Limited via slump sale, with an initial consideration of ₹23.7 crore and additional consideration of up to ₹23.0 crore linked to FY 2027-28 sales, capped at ₹46.7 crore. The acquisition is expected to close on or before November 1, 2026, and is aimed at strengthening Jagsonpal's presence in women's health and complementary therapeutic segments. The portfolio's FY 2025-26 turnover was ₹24.6 crore, and the deal is not a related-party transaction.
- · The acquisition is by way of slump sale on a going-concern basis.
- · The transaction is not a related-party transaction; no promoter/group companies have interest in the seller or portfolio.
- · The acquisition is expected to complete on or before 01 November 2026, subject to conditions precedent.
- · The portfolio has presence in India and includes identified products, assets, contracts, employees, and arrangements.
- · Jagsonpal has over five decades of track record and focuses on Gynaecology, Orthopaedics, and Dermatology segments.
- · Jagsonpal has an experienced sales team of over 1000 professionals and 20+ brands among Top 5 in their molecule category.
23-09-2026
SEBI issued a General Remittance Order dated September 23, 2026, under Recovery Certificate No. 8933 of 2025 against Pinal Rajesh Mehta, the legal representative of the deceased Rajesh Rajnikant Mehta, in the matter of Jay Energy and S. Energies Limited. The order directs compliance with recovery proceedings, indicating an ongoing enforcement action against the defaulter. No financial amounts or company-specific operational impacts are disclosed in this filing.
- · Recovery Certificate No. 8933 of 2025 was issued against the defaulter.
- · The order is part of SEBI's recovery proceedings under its enforcement framework.
- · The defaulter is identified as the legal representative of a deceased individual, indicating the recovery action is being pursued against the estate.
23-09-2026
Jindal Leasefin Limited has withdrawn its open offer by M/s. Tirupati Agrotech Private Limited to acquire 7,82,314 equity shares (26% of paid-up capital) after the Reserve Bank of India (RBI) did not approve the proposed change in management. The withdrawal is made under Regulation 23 of the SEBI SAST Regulations, 2011, following RBI's communication dated September 22, 2026. This regulatory rejection halts the acquisition and control transfer, representing a significant setback for the acquirer's plans.
- · RBI's non-approval was communicated on September 22, 2026.
- · The open offer withdrawal is under Regulation 23 of the SEBI SAST Regulations, 2011.
- · The filing is dated September 23, 2026.
23-09-2026
Zuari Industries Limited (ZIL) acquired 1,28,10,900 equity shares of Texmaco Infrastructure & Holdings Limited (TIHL) from its wholly-owned subsidiary, Zuari International Limited, for a total consideration of approximately Rs. 147,96,05,468 (₹147.96 Crore). The acquisition, approved by the Board on 13 August 2026, was executed via a block deal on 23 September 2026 to consolidate the investment portfolio at the holding company level. While ZIL's stake in TIHL increased from 20.78% to 30.83%, the overall promoter and promoter group shareholding in TIHL remained unchanged at 66.55%, and the transaction is a related party transaction between the company and its wholly-owned subsidiary.
- · The acquisition was executed via a block deal on the National Stock Exchange of India Ltd.
- · The transaction is a related party transaction (RPT) between ZIL and its wholly-owned subsidiary, ZIntL.
- · The provisions of regulation 23 of SEBI Listing Regulations regarding RPTs are not applicable as the transaction is between the company and its wholly-owned subsidiary.
- · Both ZIL and ZIntL form part of the promoter and promoter group of TIHL.
- · TIHL's standalone turnover for FY 2024-25 was Rs. 9.16 Crore, a slight decline from Rs. 9.33 Crore in FY 2023-24.
- · TIHL was incorporated on 4 August 1939 and is concentrated in Real Estate, Mini Hydel Power, and Investments.
23-09-2026
Winsome Yarns Limited reported unaudited standalone financial results for the quarter ended June 30, 2026, showing a net loss of ₹332 Lakhs, slightly wider than the ₹321 Lakhs loss in the preceding quarter but similar to the ₹328 Lakhs loss in the same quarter last year. The company remains under Corporate Insolvency Resolution Process (CIRP) with a resolution plan from Mohini Health & Hygiene Limited valued at ₹162.90 crore approved by NCLT on April 16, 2026, though implementation is still in progress. The auditors issued a qualified conclusion citing accumulated losses, negative net worth, and weak internal controls, while also noting that the company has had zero revenue from operations for the current quarter.
- · The company reported zero income from operations for the quarter ended June 30, 2026, compared to ₹18 Lakhs in the same quarter last year.
- · Depreciation & Amortisation expense of ₹242 Lakhs was the largest expense item, exceeding total revenue.
- · A theft of a transformer was reported, with an approximate loss of ₹59,20,000, and an insurance claim has been filed.
- · The company's registered office was vacated by the Chandigarh Administration on December 30, 2024, and it is currently operating from a knitting unit in Mohali.
- · The auditors noted that the company has not made provisions for demands raised by various authorities, as matters are pending before appellate forums.
- · The company's net worth remains deeply negative at ₹-52,047 Lakhs as of the previous year-end.
- · Basic and Diluted EPS for the quarter was ₹-0.47, compared to ₹-0.46 in the same quarter last year.
23-09-2026
Reliance Home Finance Limited (in CIRP) filed a post-facto intimation with BSE and NSE regarding the 14th meeting of its Committee of Creditors held on September 17, 2026, via video conferencing. The meeting is part of the ongoing Corporate Insolvency Resolution Process initiated in September 2025. No financial figures or resolution outcomes were disclosed in the filing.
- · CIRP initiated on September 20, 2025
- · 14th CoC meeting held on September 17, 2026 at 03:00 PM IST via video conferencing
- · Resolution Professional: Umesh Balaram Sonkar, IBBI Reg. No: IBBI/IPA-001/IP-P-02619/2021-2022/14043
- · BSE Scrip Code: 540709, NSE Symbol: RHFL, ISIN: INE217Ko1011
- · No resolution plan or financial outcome was disclosed in the filing
23-09-2026
Power Grid Corporation of India Limited (POWERGRID) has acquired 100% of Barmer HVDC Power Transmission Limited for an aggregate value of about ₹18.98 Crore under the tariff-based competitive bidding (TBCB) route. The project involves establishing a 6,000 MW ±800 kV HVDC transmission system to evacuate power from Rajasthan's renewable energy zone, including terminals, bipole lines, and synchronous condensers. The target entity has no prior turnover as it is yet to commence commercial operations.
- · The acquisition was completed on September 23, 2026, the same date as the filing.
- · The project will be executed on a build, own, operate and transfer (BOOT) basis.
- · The HVDC bipole line traverses through Rajasthan, Gujarat, and Maharashtra.
- · Approvals for Grant of Transmission License and Adoption of Transmission Charges are pending from the Central Electricity Regulatory Commission (CERC).
- · The acquisition price is subject to adjustment based on audited accounts as of the acquisition date.
23-09-2026
JBCG Advisory Services Private Limited, along with PACs Jaspal Singh Bindra and Chandir Gobind Gidwani, has announced an open offer to acquire up to 18,36,696 equity shares (3.60% of the emerging equity capital) of Oscar Global Limited at ₹10.00 per share. The offer is triggered by a proposed preferential issue of 4,77,16,400 shares (₹47.71 Cr) and a share swap for Calculus Travel Ventures Private Limited, which will massively dilute existing public shareholders. However, the open offer is limited to only 3.60% of the emerging capital because the preferential allottees (holding 25.89%) are ineligible to participate, meaning the offer cannot meet the minimum 26% requirement under SEBI SAST regulations.
- · The open offer is for 18,36,696 shares at ₹10.00 each, representing only 3.60% of the emerging equity capital.
- · The offer cannot meet the minimum 26% requirement because 25.89% of the emerging capital (1,32,06,400 shares) is held by ineligible preferential allottees.
- · The Acquirer is also acquiring 14,46,904 shares (44.06% of existing capital) from promoters via a separate Share Purchase Agreement.
- · Post-completion, the Acquirer and PACs will control a substantial majority of the company through the share swap (67.70%) and preferential allotment.
- · The partly paid-up shares (16,400) do not carry voting rights under the company's Articles of Association.
23-09-2026
Go Digit General Insurance Limited (GDGIL) has updated its Scheme of Amalgamation with Go Digit Infoworks Services Private Limited (GDISPL) to include a reference to Section 35 of the Insurance Act, 1938, as advised by IRDAI via email on 4th September 2026. The changes are limited to regulatory compliance and do not alter the substance or material terms of the Scheme. The Scheme remains subject to approvals from NCLT, IRDAI, and shareholders.
- · IRDAI advised the company via email dated 4th September 2026 to prepare the Scheme under Section 35 of the Insurance Act, 1938 (as amended by the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Act, 2025).
- · The Scheme is being amalgamated under Sections 230 to 232 of the Companies Act, 2013, read with Section 35 of the Insurance Act, 1938.
- · Previous submissions on the Scheme were made on 19th December 2025, 23rd April 2026, 29th July 2026, 14th August 2026, and 1st September 2026.
- · The revised Scheme is enclosed as Annexure 2, and a table of comparative changes is provided in Annexure 1.
- · The Scheme remains subject to approval from the Honourable National Company Law Tribunal, Mumbai Bench, IRDAI, and shareholders.
23-09-2026
Leader's Advantage Acquisition Corp., a blank check company, priced its $150 million initial public offering of 15,000,000 units at $10.00 per unit, with units to begin trading on Nasdaq on September 18, 2026 under 'LEDRU'. The offering is expected to close on September 21, 2026, and the company intends to focus on a business combination in healthcare, specialty chemicals, pharmaceutical, and defense industries. The company has not yet identified a target business, and there is no guarantee that a business combination will be completed.
- · The company is a newly organized blank check company with no specific target business identified yet.
- · The company intends to focus on established businesses of scale in healthcare, specialty chemicals, pharmaceutical, and defense industries.
- · The registration statement on Form S-1 (File No. 333-296772) was declared effective by the SEC on September 17, 2026.
- · The units will trade on the Nasdaq Global Market under the ticker 'LEDRU' starting September 18, 2026.
- · Once separate trading begins, Class A ordinary shares and warrants are expected to trade under 'LEDR' and 'LEDRW', respectively.
- · The offering is expected to close on September 21, 2026, subject to customary closing conditions.
- · The underwriters have a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments.
23-09-2026
Theravance Biopharma, Inc. is being acquired by Zymeworks Inc. via a merger, with shareholders receiving Contingent Value Rights (CVRs) entitling them to potential future cash payments tied to the performance of the drug ampreloxetine. Key CVR milestones include a $0.93 per CVR payment upon the first commercial sale in a major market and 80% of net license proceeds from any out-licensing of the CVR product. The CVRs expire 10 years after the closing date, and the agreement outlines detailed definitions for net sales, royalties, and payment mechanics.
- · The CVRs are non-transferable except in limited circumstances (e.g., via will or laws of descent).
- · The CVR Payment Amount for royalties is calculated by dividing Royalties by the total number of outstanding CVRs.
- · Net License Proceeds exclude consideration specifically identified as reimbursement for R&D or patent prosecution costs.
- · A Change of Control of Parent will not be deemed to create Net License Proceeds unless the CVR Product represents all or substantially all of Parent's assets at that time.
- · The CVR Register will be maintained by Computershare as Rights Agent.
23-09-2026
Nasdaq Stock Market LLC filed a Form 25-NSE to delist the securities of ONE Nuclear Energy Inc. (formerly Hennessy Capital Investment Corp. VII) from Nasdaq, effective September 23, 2026. The delisting is based on Rule 17 CFR 240.12d2-2(a)(3), which typically applies when the company has failed to meet continued listing standards or has voluntarily withdrawn its securities. This action removes the company's Rights and Units from trading on the exchange.
- · The delisting is effective as of September 23, 2026.
- · The company's securities were delisted under SEC Rule 17 CFR 240.12d2-2(a)(3).
- · The company changed its name from Hennessy Capital Investment Corp. VII to ONE Nuclear Energy Inc. on February 16, 2021.
- · The delisted securities are Rights and Units.
- · The filing was made by Nasdaq Stock Market LLC, not the company itself.
23-09-2026
Theravance Biopharma, Inc. (TBPH) filed a Form 25-NSE with the SEC on September 23, 2026, notifying the delisting of its ordinary shares from the Nasdaq Stock Market. The delisting is effective as of the same date and is being conducted under SEC Rule 17 CFR 240.12d2-2(a)(3), which typically applies to voluntary or involuntary removal of securities from exchange listing. This filing marks the formal termination of the company's Nasdaq listing.
- · Filing type: 25-NSE (Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934)
- · SEC file number: 001-36033
- · Effectiveness date: September 23, 2026
- · Delisting rule cited: 17 CFR 240.12d2-2(a)(3)
- · Company incorporated in California, with business address in Grand Cayman, Cayman Islands
- · Company headquarters: 901 Gateway Boulevard, South San Francisco, California 94080
23-09-2026
Constellation Acquisition Corp I (CSTWF) filed an 8-K on September 23, 2026, disclosing that HiTech Minerals CEO Ian Rodger participated in a Water Tower Research conference fireside chat to discuss the proposed business combination between CSTA, HiTech, and PubCo (US Elemental Inc.). The filing includes a transcript of the discussion and forward-looking statements regarding the deal, anticipated Nasdaq listing, and projected operational metrics such as lithium resource estimates and production plans. No specific financial results or quantitative updates were provided in this disclosure.
- · The business combination was previously announced on September 16, 2026.
- · PubCo (US Elemental Inc.) anticipates listing on Nasdaq after the deal closes.
- · Forward-looking statements reference lithium resource estimates, NPV, post-tax IRR, and planned production per year, but no specific figures are provided in this filing.
- · The filing is a Regulation FD disclosure and the transcript is furnished, not filed, under the Exchange Act.
- · A Registration Statement on Form S-4 is being prepared and has not yet been declared effective by the SEC.
23-09-2026
Cayson Acquisition Corp issued a $60,000 promissory note to its Chairman and CEO, Yawei Cao, on September 23, 2026. The note is non-interest bearing and is repayable only upon the consummation of a business combination; if no deal occurs, the note is forgiven unless funds are available outside the trust account. This is a routine financing arrangement to support the SPAC's operations while it seeks a merger target.
- · The note is unsecured and bears no interest.
- · Repayment is contingent on the consummation of a business combination; if no deal occurs, the note is forgiven unless funds are available outside the trust account.
- · The note includes standard events of default and remedies, including acceleration upon bankruptcy or failure to pay.
- · The note is governed by New York law.
23-09-2026
SCWorx Corp. (WORX) received a Nasdaq Hearings Panel decision on September 17, 2026, to delist its common stock due to non-compliance with the Publicly Held Shares Rule following a reverse stock split. However, the company had completed a private placement of 350,000 shares and related warrant exercises on September 16, 2026, which it believes cures the deficiency, and has submitted a formal request for reconsideration based on a mistake of material fact. The stock continues to trade on the OTCQB Venture Market, but the company faces a critical deadline of October 5, 2026, to also demonstrate a closing bid price of at least $1.00 for 10 consecutive trading days to regain full compliance with the Bid Price Rule.
- · Trading in WORX common stock on Nasdaq has been suspended since April 14, 2026.
- · The company effected a 1-for-12 reverse stock split on August 3, 2026, and subsequently met the 20 consecutive trading day bid price requirement by August 31, 2026.
- · The reverse stock split caused the publicly held shares to fall below 500,000, triggering the Publicly Held Shares deficiency.
- · The Panel Decision was issued on September 17, 2026, without knowledge of the completed private placement.
- · The company has until October 5, 2026, to evidence a closing bid price of at least $1.00 for 10 consecutive trading days to regain Bid Price Rule compliance.
- · If the private placement purchasers exercise their termination rights, the company must return $938,000, and the 350,000 shares and warrants would be cancelled.
- · The company may request review by the Nasdaq Listing and Hearing Review Council on or before October 2, 2026.
23-09-2026
International Media Acquisition Corp. (IMAQ) deposited $2,000 into its trust account on September 23, 2026, to extend the deadline to complete a business combination from October 2, 2026 to November 2, 2026. This is the 22nd of 24 permitted monthly extensions and shows the SPAC is actively buying time to close a target deal. The filing highlights the company's ongoing pursuit of an initial business combination, but no deal has been announced yet.
- · Trust agreement originally dated July 28, 2021, and amended multiple times (July 26, 2022; January 27, 2023; July 31, 2023; January 2, 2024; December 31, 2024)
- · Company is an emerging growth company as defined under SEC rules
- · No trading exchange information provided for the listed securities (marked as 'None')
- · The extension letter was issued on September 22, 2026, and filed on September 23, 2026
23-09-2026
Range Capital Acquisition Corp. (RANGU) disclosed a $60,000 drawdown on September 22, 2026, from its existing unsecured promissory note with its sponsor, bringing the total outstanding under the note to $240,000. The funds were deposited into the trust account established for its IPO, supporting the company's ongoing efforts to consummate an initial business combination. The note, which can be drawn up to $540,000, matures upon the earlier of a business combination or winding up, with repayment limited to funds outside the trust account if no deal occurs.
- · The note does not bear interest.
- · The note was issued under the exemption from registration in Section 4(a)(2) of the Securities Act of 1933.
- · The sponsor or its designees had previously committed to contributions of up to $60,000 per month to the trust account.
- · The note is subject to customary events of default, with certain defaults automatically triggering immediate repayment of the unpaid principal and all other sums payable.
23-09-2026
StepStone Private Markets filed a final amendment to its tender offer statement, reporting the results of an issuer tender offer that expired on September 15, 2026. The Fund purchased shares of beneficial interest up to 5% of outstanding shares, paying 100% of unaudited net asset value. Total consideration paid was approximately $146.4 million across three share classes: Class I ($124.8M), Class D ($0.8M), and Class S ($20.9M). The offer was fully subscribed and completed without any noted shortfall or proration, indicating strong shareholder participation.
- · Tender offer expired at 4:00 p.m. ET on September 15, 2026.
- · Valuation date for tendered shares was September 15, 2026.
- · Payments were remitted to shareholders on September 17, 2026.
- · The offer was for up to 5% of outstanding shares of the Fund.
- · Shareholders received 100% of unaudited net asset value for tendered shares.
23-09-2026
Patrick Industries and LCI Industries have entered into a merger agreement to combine their businesses, creating a premier component solutions provider for the global outdoor recreation, housing, and transportation markets. Under the terms, each LCI share will be converted into 1.2440 Patrick shares, with Patrick shareholders expected to own approximately 52% and LCI stockholders approximately 48% of the combined company. The merger requires shareholder approvals at special meetings, and the exchange ratio is fixed, with the value of the consideration fluctuating with Patrick's stock price.
- · Exchange ratio: 1.2440 Patrick shares per LCI share, fixed and not adjusted for market price changes.
- · Patrick common stock trades on Nasdaq under 'PATK'; LCI common stock trades on NYSE under 'LCII'.
- · Patrick's corporate name may be changed to a new name (not disclosed) upon approval of articles amendment.
- · Patrick special meeting proposals include: share issuance, authorized stock increase, articles amendment and restatement, and adjournment.
- · LCI special meeting proposals include: merger adoption, advisory compensation, and adjournment.
- · Both boards unanimously recommend approval of all proposals.
- · Merger cannot complete without LCI stockholder approval and Patrick shareholder approval of share issuance and authorized stock increase.
- · Risk factors section begins on page 38 of the proxy statement/prospectus.
- · Special meetings will be held virtually; dates not disclosed in this filing.
23-09-2026
SEI Structured Credit Fund, LP filed a Schedule TO-I with the SEC on September 23, 2026, announcing a tender offer to repurchase up to $79,680,000 of its limited partnership interests. The offer period runs from September 25, 2026 to October 26, 2026, with the purchase price based on net asset value as of December 31, 2026. As of August 31, 2026, approximately $1.63 billion of interests were outstanding, and the fund expects to conduct similar repurchase offers quarterly.
- · The tender offer is an issuer tender offer subject to Rule 13e-4 under the Securities Exchange Act of 1934.
- · The fund is a closed-end, non-diversified management investment company registered under the Investment Company Act of 1940.
- · Interests are not traded in any market and transfers are strictly limited by the Partnership Agreement.
- · The fund expects the Adviser to recommend quarterly repurchase offers as of the last business day of March, June, September, and December, but the Board is not obligated to follow such recommendations.
- · No persons have been employed or compensated to make solicitations or recommendations in connection with the offer.
- · The fund does not hold any Interests in treasury, and the General Partner and directors do not beneficially own any Interests.
23-09-2026
Lakeshore Acquisition III Corp. received Nasdaq approval to transfer the listing of its units, ordinary shares, and rights from the Nasdaq Global Market to the Nasdaq Capital Market, effective September 24, 2026. The securities will continue trading under the same ticker symbols (LCCCU, LCCC, LCCCR). This transfer is typically associated with a company that may not meet the stricter listing requirements of the Global Market, but the filing does not disclose any specific deficiency or financial impact.
- · Transfer effective at the opening of business on September 24, 2026.
- · The company is an emerging growth company as defined under SEC rules.
- · The company's principal executive offices are located at 667 Madison Avenue, New York, NY 10065.
23-09-2026
John Hancock Comvest Private Income Fund filed a final amendment to its tender offer statement, reporting that the offer to purchase up to 951,485.51 of its outstanding shares expired on September 18, 2026. No shares were validly tendered, and the Fund accepted no shares for purchase. The offer was a cash tender at net asset value per share as of September 30, 2026.
- · Offer expired at 11:59 p.m. Eastern Time on September 18, 2026
- · Valuation date for net asset value per share was September 30, 2026
- · Filing is a final amendment (Amendment No. 1) to the Schedule TO filed August 19, 2026
- · No shares were accepted for purchase due to zero valid tenders
23-09-2026
Aditxt, Inc. (ADTX) announced that Nasdaq will file a Form 25 with the SEC to complete the delisting of its common stock, effective ten days after filing. Trading on Nasdaq has been suspended since June 25, 2026, and the stock now trades on the OTC Market. The delisting follows the denial of the company's request for continued listing by the Nasdaq Hearings Panel on June 23, 2026.
- · Trading in Aditxt's common stock on Nasdaq has been suspended since June 25, 2026.
- · The Nasdaq Hearings Panel denied the company's request for continued listing on June 23, 2026.
- · The delisting becomes effective ten days after Nasdaq files Form 25 with the SEC.
- · The company's common stock is currently quoted on the OTC Market.
23-09-2026
Columbus Acquisition Corp (COLAR) announced the reconvened Extraordinary General Meeting for September 28, 2026, to vote on the proposed business combination with WISeSat.Space Corp. The meeting was originally adjourned on September 10, 2026, without any proposals being voted on. As of September 23, 2026, the trust holds approximately $10.79 per share, and the extended redemption deadline for public shareholders is September 24, 2026.
- · The original Extraordinary General Meeting was held on September 10, 2026, but was adjourned without any proposals being submitted to a shareholder vote.
- · The record date for voting remains August 17, 2026; shareholders who sold shares after that date are still eligible to vote.
- · Shareholders who already submitted redemption requests may withdraw them by contacting the transfer agent.
- · The company is a blank check company (SPAC) led by Fen 'Eric' Zhang (Chairman and CEO) and Jie 'Janet' Hu (CFO).
23-09-2026
Bow River Capital Evergreen Fund filed a final amendment to its tender offer statement, reporting the results of its offer to repurchase up to 5% of its shares (1,158,282 shares). The offer expired on August 17, 2026, and the Fund accepted tenders with a total net asset value of $16,471,542 for Class I shares and $512,553 for Class II shares as of the August 31, 2026 valuation date. The filing confirms the completion of the repurchase, with payments made to tendering shareholders.
- · Tender offer first published on July 24, 2026.
- · Offer expired at 11:59 p.m. Eastern Time on August 17, 2026.
- · Valuation date for tendered shares was August 31, 2026.
- · Filing is a final amendment reporting results of the tender offer.
23-09-2026
Apogee Enterprises completed its acquisition of GroGlass, a Latvian provider of anti-reflective coatings, for up to approximately $71.8 million including contingent earnout. The deal strengthens Apogee's Performance Surfaces portfolio with differentiated technology and premium brands. No financial performance metrics or period-over-period comparisons were provided in this filing.
- · GroGlass is located in Riga, Latvia.
- · GroGlass serves global end markets including museums, electronics, and architectural design.
- · The acquisition was completed following satisfaction of customary closing conditions.
- · The filing includes no financial performance data for either company.
23-09-2026
Zymeworks Inc. completed its acquisition of Theravance Biopharma, adding commercial assets like YUPELRI® and royalty interests in TRELEGY® to create a diversified revenue-generating biotechnology company. The deal advances Zymeworks' strategy of combining innovative R&D with growing commercial cash flows, though the press release does not provide specific transaction financial terms or post-acquisition revenue or cost metrics to assess immediate performance contrast.
- · A conference call with Zymeworks management is scheduled for September 28 at 8:30 am ET to discuss final transaction details.
- · Zymeworks' asset aggregation strategy includes a growing portfolio of commercial/near-commercial assets and a differentiated internal R&D engine.
- · The forward-looking statements caution that anticipated benefits of the acquisition may not be realized within the expected timeframe, and TRELEGY® may not achieve anticipated sales resulting in unmet milestones.
Get daily alerts with 11 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 40 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Global High-Priority Regulatory Events
September 21, 2026
Global High-Priority Regulatory Events — September 21, 2026
September 17, 2026
Global High-Priority Regulatory Events — September 17, 2026
September 16, 2026
Global High-Priority Regulatory Events — September 16, 2026
September 15, 2026
Global High-Priority Regulatory Events — September 15, 2026
🇺🇸 More from United States
View all →September 23, 2026
US Pre-Market SEC Filings Roundup — September 23, 2026
US Pre-Market SEC Filings Roundup
September 23, 2026
USA Corporate Events Calendar — September 23, 2026
USA Corporate Events Calendar
September 23, 2026
USA Insider Trading Pulse — September 23, 2026
USA Insider Trading Pulse
September 23, 2026
US Earnings Financial Results SEC Filings — September 23, 2026
US Earnings Financial Results SEC Filings